Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SIEMENS HEALTHINEERS AG

(SHL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Siemens Healthineers : Healthineers post Q2 FY2021 Consensus for FY2021 - FY2024 - Apr. 28, 2021 (xlsx)

05/27/2021 | 03:53am EDT
SH consensus summary FY 21-24
Vara Research Siemens Healthineers Post Q2 2021 Earnings Estimates as of May 27th, 2021
FY 2020 FY 2021 E FY 2022 E FY 2023 E FY 2024 E
Revenue
- Number of Estimates 13 13 13 9
- Highest 17,539 19,932 21,474 22,978
- Consensus 14,460 17,377 19,369 20,503 21,648
- Median 17,414 19,379 20,545 21,659 ensus
- Lowest 17,140 18,984 19,858 20,698
Comparable growth rate (in %)
- Number of Estimates 9 9 9 7
- Highest 16.4 7.7 7.0 6.6
- Consensus -0.2 15.1 2.7 5.7 5.7
- Median 15.3 1.8 5.7 5.7
- Lowest 13.7 1.2 4.5 4.1
Adjusted EBIT (SHS definition)
- Number of Estimates 13 13 13 9
- Highest 3,159 3,880 4,375 4,890
- Consensus 2,248 3,099 3,532 3,907 4,294
- Median 3,108 3,486 3,836 4,174
- Lowest 3,042 3,409 3,751 4,074
EPS reported (in EUR)
- Number of Estimates 12 12 12 9
- Highest 1.57 1.88 2.07 2.40
- Consensus 1.41 1.43 1.65 1.95 2.17
- Median 1.43 1.62 1.94 2.13
- Lowest 1.26 1.52 1.84 2.06
Adjusted EPS (in EUR)
- Number of Estimates 13 13 13 9
- Highest 2.01 2.27 2.55 2.90
- Consensus 1.61 1.98 2.19 2.44 2.68
- Median 1.99 2.18 2.44 2.66
- Lowest 1.94 2.14 2.35 2.56
DPS (in EUR)
- Number of Estimates 11 11 11 6
- Highest 1.20 1.33 1.53 1.74
- Consensus 0.80 0.84 0.98 1.12 1.29
- Median 0.85 0.93 1.08 1.20
- Lowest 0.69 0.80 0.92 1.04
This report was prepared by Vara Research GmbH for informational purposes only and is not intended to provide investment advice. It is based on an evaluation of past and an estimation of future earnings and performance of the relevant company by various market analysts. Owing to their subjective character, such estimates and forecasts cannot be independently verified. Despite careful review, Vara Research GmbH cannot provide any guarantee, assurance or warranty as to completeness or accuracy; responsibility or liability is therefore excluded. This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness. This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness. This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness. This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness. This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.

Disclaimer

Siemens Healthineers AG published this content on 27 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 May 2021 07:52:05 UTC.


ę Publicnow 2021
All news about SIEMENS HEALTHINEERS AG
08/03SIEMENS : drives digital transformation at its Virtual Smart Mining Forum
AQ
08/03SIEMENS : drives digital transformation at its Virtual Smart Mining Forum Siemen..
AQ
08/03SIEMENS HEALTHINEERS : Buy rating from Credit Suisse
MD
08/02DGAP-CMS : Siemens Healthineers AG: Release of a capital market information
DJ
08/02SIEMENS HEALTHINEERS : DZ Bank remains Neutral
MD
08/02SIEMENS HEALTHINEERS : Buy rating from Kepler Cheuvreux
MD
07/30SIEMENS HEALTHINEERS : JP Morgan gives a Buy rating
MD
07/30SIEMENS HEALTHINEERS : Barclays remains Neutral
MD
07/30SIEMENS HEALTHINEERS : Gets a Buy rating from Berenberg
MD
07/30SIEMENS HEALTHINEERS : JP Morgan reiterates its Buy rating
MD
More news
Financials
Sales 2021 17 705 M 20 950 M 20 950 M
Net income 2021 1 670 M 1 976 M 1 976 M
Net Debt 2021 13 413 M 15 872 M 15 872 M
P/E ratio 2021 36,0x
Yield 2021 1,58%
Capitalization 64 891 M 76 803 M 76 787 M
EV / Sales 2021 4,42x
EV / Sales 2022 4,00x
Nbr of Employees 54 300
Free-Float 24,6%
Chart SIEMENS HEALTHINEERS AG
Duration : Period :
Siemens Healthineers AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SIEMENS HEALTHINEERS AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Last Close Price 57,80 €
Average target price 56,35 €
Spread / Average Target -2,51%
EPS Revisions
Managers and Directors
Bernhard Montag Chief Executive Officer
Jochen Schmitz Chief Financial Officer
Ralf Peter Thomas Chairman-Supervisory Board
Thorsten Opderbeck Head-Technology, Trade & Regional Media
A. Gregory Sorensen Member-Supervisory Board
Sector and Competitors